Roy N. Envall Jr.

Array ( [id] => 6731070 [patent_doc_number] => 20030187260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Thienopyrimidines' [patent_app_type] => new [patent_app_number] => 10/362993 [patent_app_country] => US [patent_app_date] => 2003-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6897 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20030187260.pdf [firstpage_image] =>[orig_patent_app_number] => 10362993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730781 [patent_doc_number] => 20030186971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases' [patent_app_type] => new [patent_app_number] => 10/363290 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6120 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186971.pdf [firstpage_image] =>[orig_patent_app_number] => 10363290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 961137 [patent_doc_number] => 06951850 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-04 [patent_title] => 'Dipeptide derivatives' [patent_app_type] => utility [patent_app_number] => 10/371953 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63047 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/951/06951850.pdf [firstpage_image] =>[orig_patent_app_number] => 10371953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 985552 [patent_doc_number] => 06924280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-02 [patent_title] => 'Dipeptide derivatives' [patent_app_type] => utility [patent_app_number] => 10/371330 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62949 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924280.pdf [firstpage_image] =>[orig_patent_app_number] => 10371330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 958845 [patent_doc_number] => 06953791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-11 [patent_title] => 'Dipeptide derivatives' [patent_app_type] => utility [patent_app_number] => 10/371315 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62927 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/953/06953791.pdf [firstpage_image] =>[orig_patent_app_number] => 10371315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835238 [patent_doc_number] => 20030162784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Pyridazinone aldose reductase inhibitors' [patent_app_type] => new [patent_app_number] => 10/370895 [patent_app_country] => US [patent_app_date] => 2003-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29826 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162784.pdf [firstpage_image] =>[orig_patent_app_number] => 10370895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073809 [patent_doc_number] => 06838474 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-04 [patent_title] => 'Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors' [patent_app_type] => utility [patent_app_number] => 10/370171 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18370 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838474.pdf [firstpage_image] =>[orig_patent_app_number] => 10370171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468409 [patent_doc_number] => 20040053951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Non-peptide GnRH agents, pharmaceutical compositions, and methods for their use' [patent_app_type] => new [patent_app_number] => 10/364193 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37725 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053951.pdf [firstpage_image] =>[orig_patent_app_number] => 10364193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6731062 [patent_doc_number] => 20030187252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Porphyrin compounds consisting of porphyrin rings fused in a single direction by three bonds, i.e., one meso-meso carbon bond and two beta-beta carbon bonds and process for their synthesis' [patent_app_type] => new [patent_app_number] => 10/343920 [patent_app_country] => US [patent_app_date] => 2003-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4521 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20030187252.pdf [firstpage_image] =>[orig_patent_app_number] => 10343920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136406 [patent_doc_number] => 20040044048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => '(R)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity' [patent_app_type] => new [patent_app_number] => 10/357960 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57850 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20040044048.pdf [firstpage_image] =>[orig_patent_app_number] => 10357960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136477 [patent_doc_number] => 20040044062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Method of treatment of viral infection including HIV using water soluble fullerenes - III' [patent_app_type] => new [patent_app_number] => 10/355365 [patent_app_country] => US [patent_app_date] => 2003-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11554 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20040044062.pdf [firstpage_image] =>[orig_patent_app_number] => 10355365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1081030 [patent_doc_number] => 06835838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-28 [patent_title] => 'Process for the manufacture of organic compounds' [patent_app_type] => B2 [patent_app_number] => 10/350615 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7954 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835838.pdf [firstpage_image] =>[orig_patent_app_number] => 10350615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7620011 [patent_doc_number] => 06943172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-13 [patent_title] => 'Rho-kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/349176 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10125 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/943/06943172.pdf [firstpage_image] =>[orig_patent_app_number] => 10349176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 985562 [patent_doc_number] => 06924290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-02 [patent_title] => 'Rho-kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/349177 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12119 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924290.pdf [firstpage_image] =>[orig_patent_app_number] => 10349177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730805 [patent_doc_number] => 20030186995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Substituted bicyclic derivatives useful as anticancer agents' [patent_app_type] => new [patent_app_number] => 10/349475 [patent_app_country] => US [patent_app_date] => 2003-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32717 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186995.pdf [firstpage_image] =>[orig_patent_app_number] => 10349475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788186 [patent_doc_number] => 20030139425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Piperazine derivatives and their use as anti-inflammatory agents' [patent_app_type] => new [patent_app_number] => 10/347530 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80284 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139425.pdf [firstpage_image] =>[orig_patent_app_number] => 10347530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 938461 [patent_doc_number] => 06972290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-06 [patent_title] => 'Piperazine derivatives and their use as anti-inflammatory agents' [patent_app_type] => utility [patent_app_number] => 10/347529 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77628 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/972/06972290.pdf [firstpage_image] =>[orig_patent_app_number] => 10347529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207397 [patent_doc_number] => 20040087589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'CRF receptor antagonists and methods relating thereto' [patent_app_type] => new [patent_app_number] => 10/339780 [patent_app_country] => US [patent_app_date] => 2003-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26949 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087589.pdf [firstpage_image] =>[orig_patent_app_number] => 10339780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669687 [patent_doc_number] => 20030114671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Substituted6,6-hetero-bicyclicderivatives' [patent_app_type] => new [patent_app_number] => 10/336884 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14611 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114671.pdf [firstpage_image] =>[orig_patent_app_number] => 10336884 [rel_patent_id] =>[rel_patent_doc_number] =>)